From: Allergen Immunotherapy (AIT): a prototype of Precision Medicine
1. Precision diagnosis aided by eHealth technologies [8, 9], enhanced Component-resolved diagnostics (CRD), genomics and other future possibilities | Â |
2. Amenability of Allergic rhinitis, asthma, co-morbid allergic diseases, venom allergy, food allergy, other diseases (eg atopic dermatitis) to treatment with AIT | Â |
3. Patient stratification aided by e-HEALTH assessment and biomarkers | Â |
4. Innovative products: recombinant allergens and new forms of AIT | Â |
5. Marketing authorization for AIT products | Â |
6. A new role of preventative immunotherapy aimed at those at high risk | Â |
7. Putting the patient at the centre: guideline informed rather than guideline directed. | Â |